Mechanisms of immunosenescence

被引：82

作者：

Caruso C. ^{[1
]}

Buffa S. ^{[1
]}

Candore G. ^{[1
]}

Colonna-Romano G. ^{[1
]}

Dunn-Walters D. ^{[2
]}

Kipling D. ^{[3
]}

Pawelec G. ^{[4
]}

机构：

[1] Immunosenescence Unit, Department of Pathobiology and Biomedical Methodologies, University of Palermo, Palermo

[2] Department of Immunobiology, King's College London, London

[3] Department of Pathology, Cardiff University, Cardiff

[4] Center for Medical Research, University of Tübingen Medical School, Tübingen

来源：

Immunity & Ageing | / 6卷 / 1期

基金：

英国医学研究理事会;

关键词：

Germinal Centre; Acquire Immunity; Immune Signature; Antagonistic Pleiotropy; Exceptional Longevity;

D O I：

10.1186/1742-4933-6-10

中图分类号：

学科分类号：

摘要：

On April 7,8, 2009 a Symposium entitled "Pathophysiology of Successful and Unsuccessful Ageing" took place in Palermo, Italy. Here, the lectures of G. Pawelec, D. Dunn-Walters and. G. Colonna-Romano on T and B immunosenescence are summarized. In the elderly, many alterations of both innate and acquired immunity have been described. Alterations to the immune system in the older person are generally viewed as a deterioration of immunity, leading to the use of the catch-all term immunosenescence. Indeed, many immunological parameters are often markedly different in elderly compared to young people, and some, mostly circumstantial, evidence suggests that retained function of both innate and acquired immunity in the elderly is correlated with health status. What is often not clear from studies is how far immune dysfunction is a cause or an effect. A better understanding of immunosenescence and mechanisms responsible for proven deleterious changes is needed to maintain a healthy state in later life and to design possible therapeutic interventions. © 2009 Caruso et al; licensee BioMed Central Ltd.

引用

共 26 条

[1]

Bruunsgaard H., The clinical impact of systemic low-level inflammation in elderly populations. With special reference to cardiovascular disease, dementia and mortality, Dan Med Bull, 53, pp. 285-309, (2006)

[2]

Larbi A., Franceschi C., Mazzatti D., Solana R., Wikby A., Pawelec G., Aging of the immune system as a prognostic factor for human longevity, Physiology (Bethesda), 23, pp. 64-74, (2008)

[3]

Licastro F., Candore G., Lio D., Porcellini E., Colonna-Romano G., Franceschi C., Innate immunity and inflammation in ageing: A key for understanding age-related diseases, Immun Ageing, 2, (2005)

[4]

Vasto S., Caruso C., Immunity & Ageing: A new journal looking at ageing from an immunological point of view, Immun Ageing, 29, (2004)

[5]

Pawelec G., Derhovanessian E., Larbi A., Strindhall J., Wikby A., Cytomegalovirus and human immunosenescence, Rev Med Virol, 19, pp. 47-56, (2009)

[6]

Pawelec G., Akbar A., Caruso C., Effros R., Grubeck-Loebenstein B., Wikby A., Is immunosenescence infectious?, Trends Immunol, 25, pp. 406-410, (2004)

[7]

Pawelec G., Akbar A., Caruso C., Solana R., Grubeck-Loebenstein B., Wikby A., Human immunosenescence: Is it infectious?, Immunol Rev, 205, pp. 257-268, (2005)

[8]

Koch S., Larbi A., Ozcelik D., Solana R., Gouttefangeas C., Attig S., Wikby A., Strindhall J., Franceschi C., Pawelec G., Cytomegalovirus infection: A driving force in human T cell immunosenescence, Ann N Y Acad Sci, 1114, pp. 23-35, (2007)

[9]

Derhovanessian E., Larbi A., Pawelec G., Biomarkers of human immunosenescence: Impact of Cytomegalovirus infection, Curr Opin Immunol, (2009)

[10]

Chidrawar S., Khan N., Wei W., McLarnon A., Smith N., Nayak L., Moss P., Cytomegalovirus-seropositivity has a profound influence on the magnitude of major lymphoid subsets within healthy individuals, Clin Exp Immunol, 155, pp. 423-432, (2009)

← 1 2 3 →